Key facts
- This page summarizes J. Rodney Varner's Form 4 filing for Genprex, Inc. (GNPX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Feb 2024, 16:32.
J. Rodney Varner - 18 Feb 2024 Form 4 Insider Report for Genprex, Inc. (GNPX)
- Reporting relationship
- Chairman, President and CEO, Director
- Issuer ticker
- GNPX
- Reported as of
- 18 Feb 2024
- Net transaction value
- -$11,625
- SEC form
- 4
- Accepted by SEC
- 21 Feb 2024, 16:32:12 UTC
- Prior SEC filing
- 24 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ J. Rodney Varner
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
J. Rodney Varner filed Form 4 for Genprex, Inc. (GNPX) on 21 Feb 2024.
Change
- Previous filing in this sequence was filed on 24 Apr 2023.
- Current net transaction value: -$11,625.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GNPX
transaction
Common Stock
Tax liability
- Transaction value
- $11,625
- Shares
- -2,642
- Change %
- -9.1%
- Price
- $4.40*
- Shares after
- 26,352
- Date
- 18 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
GNPX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 520
- Date
- 18 Feb 2024
- Ownership
- by Alizzita Ltd
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents shares withheld on February 18, 2024 to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") previously granted under the Genprex, Inc. (the "Company") 2018 Equity Incentive Plan.
Footnote F2
This total represents the number of shares of Common Stock directly beneficially owned following this reported transaction and the 1-for-40 reverse stock split of the Company's Common Stock effected as of February 2, 2024 (the "RSS").
Footnote F3
This total represents the number of shares of Common Stock indirectly beneficially owned following the RSS.